Results 21 to 30 of about 754,759 (237)
Controlling Dengue with Vaccines in Thailand
PLoS Neglected Tropical Diseases, 2012 Dengue is a mosquito-borne infectious disease that constitutes a growing global threat with the habitat expansion of its vectors Aedes aegyti and A. albopictus and increasing urbanization. With no effective treatment and limited success of vector control, dengue vaccines constitute the best control measure for the foreseeable future.
Dennis L Chao +2 more
exaly +6 more sources
Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies
Vaccines, 2023 Background: Nearly half of the world is at risk of developing dengue infection. Dengue virus is the causative agent behind this public healthcare concern. Millions of dengue cases are reported every year, leading to thousands of deaths.
Shiza Malik +5 more
doaj +2 more sources
Vaccines and immunization strategies for dengue prevention
Emerging Microbes and Infections, 2016 Dengue is currently the most significant arboviral disease afflicting tropical and sub-tropical countries worldwide. Dengue vaccines, such as the multivalent attenuated, chimeric, DNA and inactivated vaccines, have been developed to prevent dengue ...
Yang Liu, Jianying Liu, Gong Cheng
doaj +2 more sources
Current Dengue Virus Vaccine Developments and Future Directions
VirusesDengue fever (DF), a leading arboviral disease globally, is caused by the Dengue virus (DENV) and represents a significant public health concern, with an estimated 390 million cases reported annually.
Govindaraj Anumanthan +2 more
doaj +3 more sources
Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development
Viruses, 2011 Dengue has become the most important arboviral infection worldwide with more than 30 million cases of dengue fever estimated to occur each year. The need for a dengue vaccine is great and several live attenuated dengue candidate vaccines are proceeding ...
Anna P. Durbin, Stephen S. Whitehead
doaj +2 more sources
Dengue: Status of current and under‐development vaccines [PDF]
Reviews in Medical Virology, 2020 Dengue is an emerging mosquito‐borne viral infection with increasing reports of outbreaks. The clinical picture ranges from a benign febrile illness through to severe and potentially fatal manifestations.
Marianna Redoni +5 more
semanticscholar +2 more sources
A Review on Dengue Vaccine Development [PDF]
Vaccines, 2020 Dengue virus (DENV) has become a global health threat with about half of the world’s population at risk of infection. Although the disease caused by DENV is self-limiting in the first infection, the antibody-dependent enhancement (ADE) effect increases the mortality in the second infection with a heterotypic virus.
Sheng-Qun Deng +5 more
openaire +4 more sources
Determinants of felt demand for dengue vaccines in the North Caribbean region of Colombia
Annals of Clinical Microbiology and Antimicrobials, 2017 Background The increasing burden associated with dengue in Latin America makes it essential to understand the community’s interest in acquiring vaccines, as an input to plan its introduction in endemic regions. The objective of this study is to learn the
Yalil T. Bracho-Churio +5 more
doaj +2 more sources
Efficacy of Dengue Vaccines in the Prevention of Severe Dengue in Children: A Systematic Review. [PDF]
Cureus, 2022 Dengue is a vector-borne disease caused by the dengue virus (DENV) and is a major health concern worldwide, particularly in regions of endemic disease. Dengue usually presents as a self-limited febrile illness.
Foucambert P +9 more
europepmc +2 more sources
Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines. [PDF]
Front Immunol, 2022 Dengue is the most common arboviral disease caused by one of four distinct but closely related dengue viruses (DENV) and places significant economic and public health burdens in the endemic areas.
Hou J, Ye W, Chen J.
europepmc +2 more sources